Prevalence of 'high risk' human papillomavirus in the lower genital tract of Brazilian gravidas

International Journal of Gynecology and Obstetrics

Volumn 69, Issue 3, 2000, Pages 223-227

  Armbruster Moraes, E ^a,b   Ioshimoto, L M ^b   Leao, E ^a   Zugaib, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cervical carcinoma; CIN; HPV; Pregnancy; Progesterone

Indexed keywords

PROGESTERONE; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYBRIDIZATION; PAPANICOLAOU TEST; PAPILLOMATOSIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; VIRUS TYPING; WART VIRUS;

EID: 0034214259     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(00)00191-0     Document Type: Article

References (25)

1. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 184:1991;9-13.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Sha K.V. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:1999;12-19.
3. von Knebel Doeberitz M., Spitkovsky D., Ridder R. Interactions between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer. Verh Dtsch Ges Pathol. 81:1997;233-239.
4. Michelin D., Gissmann L., Street D., Potkul R.K., Fisher S., Kauffmann A.M. et al. Regulation of human papillomavirus type 18 in vivo: effect of estrogen and progesterone in transgenic mice. Gynecol Oncol. 66:1997;202-208.
5. Khare S., Pater M.M., Tang S.C., Pater A. Effect of glucocorticoid hormones on viral gene expression, grow, and dysplastic differentiation in HPV16-immortalized ectocervical cells. Exp Cell Res. 232:1997;353-360.
6. Bartholomew J.S., Glenville S., Sarkar S., Burt D.J., Stanley M.A., Ruiz Cabello F. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Res. 57:1997;937-942.
7. Crum C.P., Genest D.R., Krane J.F., Hogan C., Sun D., Bellerose B. et al. Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA. Am J Clin Pathol. 112:1999;384-390.
8. Davis GL, Dibner MD, Battery JF, Preparation of DNA from eukaryotic cells. In: Elsevier Science Publishing Co, editor. Basic methods in molecular biology New York, NY: Elsevier, 1986:42-47.
9. Nevin J., Soeters R., Dehaeck K., Bloch B., van Wyk L. Cervical carcinoma associated with pregnancy. Obstet Gynecol Surv. 50:1995;228-239.
10. Chabaud M., Le Cann P., Mayelo V., Leboulleux D., Diallo A.S., Enogat N. et al. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol. 49:1996;259-263.
11. Reeves W.C., Brinton L.A., Garcia M., Brenes M.M., Herrero R., Gaitan E. et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med. 320:1989;1437-1441.
12. Sethi S., Muller M., Schneider A., Blettner M., Smith E., Turek L. et al. Serologic response to E4, E6 and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol. 178:1998;360-364.
13. Czeglédy J., Bugely L., Endiodi J. Detection of human papillomavirus deoxyribonucleic acid by filter in situ hybridization during pregnancy. J Med Virol. 28:1989;250-254.
14. de Roda Husman A.M., Walboomers J.M., Hopman E., Bleker O.P., Helmerhorst T.M., Rozendaal L. et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol. 46:1995;97-102.
15. Morrison E.A., Gammon M.D., Goldberg G.L., Vermund S.H., Burk R.D. Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet. 54:1996;125-130.
16. Schneider A., Hotz M., Gissmann L. Inscreased prevalence of human Papillomavirus in the lower genital tract of pregnant women. Int J Cancer. 40:1987;198-201.
17. Fife K.H., Katz B.P., Brizendine E.J., Brown D.R. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 180:1999;1110-1114.
18. Schiffman M.H., Bauer H.M., Hoover R.N. Epidemiologie evidence showing that human Papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 85:1993;958-964.
19. Dürst M., Gissmann L., Ikenberg H., zur Hauzen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Soc Acad Sci USA. 80:1983;3812-3815.
20. Termeulen J., Eberhardt H.C., Luande J., Mgaya H.N., Chang Claude J., Mtiro H. et al. Human Papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer. 51:1992;515-521.
21. Dokianakis D.N., Sourvinos G., Sakkas S., Athanasiadou E., Spandidos D.A. Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Onco Rep. 5:1998;1195-1198.
22. Souen JS, Leão E, Havrenne JED, Cury M, Zugaib M. Carcinoma do colo do utero e gravidez. Experiência da Faculdade de Medicina da Universidade de Sao Paulo. Rev Bras Ginecol Obstet 1985; Set/Out:167-170.
23. Woodrow N., Permezel M., Butterfield L., Rome R., Tan J., Quinn M. Abnormal cervical cytology in pregnancy: experience of 811 cases. Aust N Z J Obstet Gynecol. 38:1998;161-165.
24. Iwasawa A., Nieminen P., Lehtinen M., Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer. 77:1996;2275-2279.
25. Hermonat P.L., Han L., Wedel P.J., Quirk J.G., Stern S., Lowery C.L., Rechtin T.M. Human papillomavirus is more prevalent in first trimester spontaneously product of conception compared to elective specimens. Virus Genes. 14:1997;13-17.